Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Dismisses Lawsuit against PacBio, Former Employees

Premium

By Julia Karow

This story was originally published March 3.

A month after suing Pacific Biosciences and several former employees for unlawfully recruiting its workers and disclosing confidential information, Affymetrix dropped the suit in December.

According to a document filed with the Santa Clara County Superior Court of California, Affymetrix asked the court to dismiss the lawsuit on Dec. 2, 2010. The company provided no explanation in the filing for why it decided to drop the action.

Rick Runkel, Affy's chief legal counsel and executive vice president, said in a statement that the company had settled its claims against PacBio but declined to comment on the terms of the settlement.

A spokesperson for PacBio told In Sequence that "the matter was resolved by mutual agreement, and involved no financial terms."

Affy filed the suit in early November of last year (IS 11/9/2010), claiming that several former employees that joined PacBio as early as 2009 had violated an agreement with Affy not to recruit other Affymetrix staff for one year after leaving the firm. The suit also alleged that PacBio and the former employees induced other Affy workers to disclose confidential information about the company.

In a filing with the Securities and Exchange Commission last November, PacBio said it believed the complaint "is entirely without merit" and intended to "vigorously" defend itself against Affymetrix' claims. PacBio further noted at the time that it had not been served with a copy of the complaint as of Nov. 29, 2010.


Have topics you'd like to see covered in In Sequence? E-mail the editor at jkarow [at] genomeweb [.] com.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.